Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

RYTMRYTM
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in RHYTHM PHARMACEUTICALS INC

JPMORGAN CHASE & CO holds 2.7M shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $292.2M as of 2026-Q2. The position was increased (+70.7% shares). RYTM represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$292.2M

Current Shares

2.7M

Total Value Change

+$277.4M

Total Shares Change

+2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.7M
+70.7%
$292.2M0.0%$111.03
46
2026-Q1
Increased
1.6M
+9.1%
$120M0.0%$89.56
33
2025-Q4
Decreased
1.4M
-40.1%
$152.4M0.0%$106.76
0
2025-Q3
Increased
2.4M
+203.3%
$240M0.0%$100.64
50
2025-Q2
Increased
783,559
+445.5%
$49.5M0.0%$62.73
47
2025-Q1
Decreased
143,640
-45.7%
$7.6M0.0%$54.80
0
2024-Q4
New
264,585
-
$14.8M0.0%$56.34
39

Other major holders of RYTM: RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used